Skeletal Biotech Laboratory, The Hebrew University-Hadassah Faculty of Dental Medicine, PO Box 12272, Ein Kerem, Jerusalem 91120, Israel.
J Biomech. 2010 Aug 26;43(12):2315-20. doi: 10.1016/j.jbiomech.2010.04.031. Epub 2010 May 14.
Stem cell-mediated gene therapy for fracture repair, utilizes genetically engineered mesenchymal stem cells (MSCs) for the induction of bone growth and is considered a promising approach in skeletal tissue regeneration. Previous studies have shown that murine nonunion fractures can be repaired by implanting MSCs over-expressing recombinant human bone morphogenetic protein-2 (rhBMP-2). Nanoindentation studies of bone tissue induced by MSCs in a radius fracture site indicated similar elastic modulus compared to intact murine bone, eight weeks post-treatment. In the present study we sought to investigate temporal changes in microarchitecture and biomechanical properties of repaired murine radius bones, following the implantation of MSCs. High-resolution micro-computed tomography (micro-CT) was performed 10 and 35 weeks post MSC implantation, followed by micro-finite element (micro-FE) analysis. The results have shown that the regenerated bone tissue remodels over time, as indicated by a significant decrease in bone volume, total volume, and connectivity density combined with an increase in mineral density. In addition, the axial stiffness of limbs repaired with MSCs was 2-1.5 times higher compared to the contralateral intact limbs, at 10 and 35 weeks post-treatment. These results could be attributed to the fusion that occurred in between the ulna and radius bones. In conclusion, although MSCs induce bone formation, which exceeds the fracture site, significant remodeling of the repair callus occurs over time. In addition, limbs treated with an MSC graft demonstrated superior biomechanical properties, which could indicate the clinical benefit of future MSC application in nonunion fracture repair.
干细胞介导的骨折修复基因治疗利用基因工程间充质干细胞(MSCs)诱导骨生长,被认为是骨骼组织再生的一种有前途的方法。先前的研究表明,通过植入过表达重组人骨形态发生蛋白-2(rhBMP-2)的 MSCs 可以修复鼠骨不连骨折。在桡骨骨折部位,MSCs 诱导的骨组织的纳米压痕研究表明,在治疗后 8 周时,与完整的鼠骨相比,其弹性模量相似。在本研究中,我们试图研究在植入 MSCs 后,修复的鼠桡骨的微观结构和生物力学性能的时间变化。在 MSC 植入后 10 和 35 周进行高分辨率微计算机断层扫描(micro-CT),然后进行微有限元(micro-FE)分析。结果表明,再生的骨组织随着时间的推移而重塑,表现为骨体积、总体积和连通密度显著降低,同时矿化密度增加。此外,与对侧完整肢体相比,用 MSCs 修复的肢体的轴向刚度在治疗后 10 和 35 周时分别提高了 2-1.5 倍。这些结果可能归因于尺骨和桡骨之间发生的融合。总之,尽管 MSCs 诱导了超过骨折部位的骨形成,但修复骨痂会随着时间的推移发生显著的重塑。此外,用 MSC 移植物治疗的肢体表现出更好的生物力学性能,这可能表明未来在骨不连骨折修复中应用 MSC 的临床益处。